Close

Ratings by Wells Fargo (Jim Birchenough)

More Stocks Rated by Wells Fargo
Date CompanySymbol Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/4/2023 Sangamo BioSciences SGMO Maintain Overweight
(N/A)		  
 		   Details
11/7/2022 Sangamo BioSciences SGMO Maintain Overweight
(N/A)		  
 		   Details
8/9/2022 uniQure BV QURE Maintain Equal Weight
(N/A)		  
 		   Details
8/9/2022 Global Blood Therapeutics GBT Downgrade Equal Weight
(Overweight)		 66.60
(68.49)		 2.84% Details
2/9/2022 Zymeworks ZYME Maintain Overweight
(N/A)		  
 		   Details
9/30/2021 Zymeworks ZYME Maintain Overweight
(N/A)		  
 		   Details
3/18/2021 Sangamo BioSciences SGMO Maintain Overweight
(N/A)		  
 		   Details
3/3/2021 Sangamo BioSciences SGMO Maintain Overweight
(N/A)		  
 		   Details
3/2/2021 Tracon Pharmaceuticals TCON Maintain Equal Weight
(N/A)		  
 		   Details
1/12/2021 Zymeworks ZYME Maintain Overweight
(N/A)		  
 		   Details
12/7/2020 CRISPR Therapeutics CRSP Downgrade Equal Weight
(Overweight)		 140.46
(52.78)		 -62.42% Details
11/23/2020 Moderna MRNA New Coverage Equal Weight
(N/A)		 97.61
(189.35)		 93.99% Details
11/17/2020 Applied Genetic Technologies Corp. AGTC Maintain Overweight
(N/A)		  
 		   Details
11/11/2020 Tracon Pharmaceuticals TCON Maintain Equal Weight
(N/A)		  
 		   Details
11/11/2020 Five Prime Therapeutics FPRX Upgrade Overweight
(Equal Weight)		 5.49
(38.00)		 592.17% Details
11/10/2020 Voyager Therapeutics VYGR Downgrade Equal Weight
(Overweight)		 10.98
(9.01)		 -17.94% Details
10/30/2020 Bellicum Pharmaceuticals BLCM Downgrade Equal Weight
(Overweight)		 6.40
(1.27)		 -80.16% Details
10/29/2020 Gilead Sciences GILD Maintain Equal Weight
(N/A)		  
 		   Details
10/15/2020 Global Blood Therapeutics GBT Maintain Overweight
(N/A)		  
 		   Details
10/5/2020 MyoKardia MYOK Downgrade Equal Weight
(Overweight)		 139.60
(224.91)		 61.11% Details
8/31/2020 Akcea Therapeutics, Inc. AKCA Downgrade Equal Weight
(Overweight)		 11.38
(18.17)		 59.67% Details
8/19/2020 Gilead Sciences GILD Maintain Equal Weight
(N/A)		  
 		   Details
8/7/2020 Principia Biopharma PRNB Maintain Overweight
(N/A)		  
 		   Details
7/28/2020 CRISPR Therapeutics CRSP Maintain Overweight
(N/A)		  
 		   Details
6/25/2020 uniQure BV QURE Downgrade Equal Weight
(Overweight)		 67.74
(21.24)		 -68.64% Details
5/26/2020 Regeneron Pharma REGN Upgrade Overweight
(Equal Weight)		 569.91
(742.83)		 30.34% Details
5/18/2020 IMV Inc. IMV Upgrade Overweight
(Equal Weight)		 2.30
(2.16)		 -6.09% Details
4/20/2020 Gilead Sciences GILD Downgrade Equal Weight
(Overweight)		 76.54
(83.73)		 9.39% Details
3/19/2020 Gilead Sciences GILD Maintain Overweight
(N/A)		  
 		   Details
3/11/2020 Sunesis Pharmaceuticals Inc. SNSS Downgrade Equal Weight
(Overweight)		 0.97
(5.32)		 448.45% Details
2/28/2020 IMV Inc. IMV Maintain Equal Weight
(N/A)		  
 		   Details
2/25/2020 IMV Inc. IMV Downgrade Equal Weight
(Overweight)		 4.78
(2.30)		 -51.88% Details
2/7/2020 Principia Biopharma PRNB Maintain Overweight
(N/A)		  
 		   Details
1/21/2020 IMV Inc. IMV Upgrade Overweight
(Equal Weight)		 4.00
(4.78)		 19.5% Details
1/15/2020 Zymeworks ZYME Maintain Overweight
(N/A)		  
 		   Details
12/17/2019 Intercept Pharmaceuticals ICPT Maintain Overweight
(N/A)		  
 		   Details
12/9/2019 Principia Biopharma PRNB Maintain Overweight
(N/A)		  
 		   Details
12/9/2019 Fate Therapeutics FATE Upgrade Overweight
(Equal Weight)		 13.57
(5.92)		 -56.37% Details
11/11/2019 Zymeworks ZYME Maintain Overweight
(N/A)		  
 		   Details
11/1/2019 Celgene CELG Maintain Equal Weight
(N/A)		  
 		   Details
10/28/2019 IMV Inc. IMV New Coverage Equal Weight
(N/A)		 2.96
(2.16)		 -27.03% Details
10/10/2019 Ionis Pharmaceuticals IONS Maintain Overweight
(N/A)		  
 		   Details
10/7/2019 Akcea Therapeutics, Inc. AKCA Upgrade Overweight
(Equal Weight)		 15.13
(11.38)		 -24.79% Details
9/23/2019 Akcea Therapeutics, Inc. AKCA New Coverage Equal Weight
(N/A)		 22.46
(15.13)		 -32.64% Details
7/15/2019 Gilead Sciences GILD Upgrade Overweight
(Equal Weight)		 66.19
(83.73)		 26.5% Details
5/3/2019 Intercept Pharmaceuticals ICPT Upgrade Overweight
(Equal Weight)		 85.82
(77.49)		 -9.71% Details
4/22/2019 Zymeworks ZYME Maintain Overweight
(N/A)		  
 		   Details
3/7/2019 Intercept Pharmaceuticals ICPT Maintain Equal Weight
(N/A)		  
 		   Details
2/28/2019 uniQure BV QURE Maintain Overweight
(N/A)		  
 		   Details
2/7/2019 Sangamo BioSciences SGMO Maintain Overweight
(N/A)		  
 		   Details
12/21/2018 Tracon Pharmaceuticals TCON Maintain Equal Weight
(N/A)		  
 		   Details
12/6/2018 OncoMed Pharmaceuticals OMED Downgrade Equal Weight
(Overweight)		 1.11
(0.89)		 -19.82% Details
12/3/2018 Tesaro TSRO Downgrade Equal Weight
(Overweight)		 46.38
(74.96)		 61.62% Details
10/31/2018 Intercept Pharmaceuticals ICPT Maintain Equal Weight
(N/A)		  
 		   Details
10/25/2018 Celgene CELG Maintain Equal Weight
(N/A)		  
 		   Details
10/10/2018 CRISPR Therapeutics CRSP New Coverage Overweight
(N/A)		 36.56
(52.78)		 44.37% Details
10/9/2018 Principia Biopharma PRNB New Coverage Overweight
(N/A)		 26.37
(100.05)		 279.41% Details
9/24/2018 Applied Genetic Technologies Corp. AGTC Upgrade Overweight
(Equal Weight)		 4.40
(0.27)		 -93.86% Details
9/4/2018 Aeglea Biotherapeutics AGLE Downgrade Equal Weight
(Overweight)		 10.93
(0.51)		 -95.33% Details
8/28/2018 Akcea Therapeutics, Inc. AKCA Maintain Overweight
(N/A)		  
 		   Details
8/28/2018 Ionis Pharmaceuticals IONS Maintain Overweight
(Overweight)		  
 		   Details